CDNS vs DMAC · P/E 82, rev $5.30B vs $157.4M cap
Cadence Design Systems Inc (CDNS) versus DiaMedica Therapeutics Inc (DMAC) — a side-by-side from cached financials, not a winner call.
Cadence Design Systems Inc (CDNS) is a software - application company listed on US.
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.
Latest reported CDNS revenue for 2025-12-31 was $5.30B. Net income was $1.11B. Revenue was up 14.1% from 2024-12-31 to 2025-12-31. CDNS currently screens at market cap $88.27B and trailing P/E 82.0.
DMAC does not have a complete income-statement cache yet.
CDNS currently screens at market cap $88.27B and trailing P/E 82.0. DMAC currently screens at market cap $157.4M.
Not investment advice. Open the CDNS and DMAC stock pages for the full models.
Not investment advice.